Crosslinking of α-synuclein by advanced glycation endproducts - An early pathophysiological step in Lewy body formation?

Journal of Chemical Neuroanatomy

Volumn 20, Issue 3-4, 2000, Pages 253-257

  Munch G ^a   Luth H J ^b   Wong, A ^a   Arendt, Th ^b   Hirsch, E ^c   Ravid, R ^d   Riederer, P ^e  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d NETHERLANDS BRAIN BANK   (Netherlands)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Advanced glycation endproducts; Lewy bodies; Neurodegeneration; Oxidative stress; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; CARBONYL DERIVATIVE; CELL PROTEIN; FREE RADICAL;

AGED; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; FEMALE; GLYCATION; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; NEUROFILAMENT; NEUROPATHOLOGY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ANIMALS; ANTIBODIES; CROSS-LINKING REAGENTS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LEWY BODIES; MALE; NERVE DEGENERATION; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; PARKINSON DISEASE; RABBITS; SOLUBILITY; SYNUCLEINS;

EID: 0034468706     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(00)00096-X     Document Type: Article

References (26)

1. Nigral and extranigral pathology in Parkinson's disease
2. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease
3. Sequestration of iron by Lewy bodies in Parkinson's disease
4. Alpha-Synuclein immunoreactivity in dementia with Lewy bodies: Morphological staging and comparison with ubiquitin immunostaining
5. Understanding cell death in Parkinson's disease
6. Amadorins: Novel post-Amadori inhibitors of advanced glycation reactions
7. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders
8. Transition metal mediated glycoxidation accelerates crosslinking of β-amyloid peptide
9. Interleukin-1-beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from Parkinsonian patients
10. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients
11. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes
12. Advanced glycation end products in neurodegeneration-more than early markers of oxidative stress
13. Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease
14. Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts
15. The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation
16. Advanced glycation endproducts in ageing and Alzheimer's disease
17. High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappa B activation and cytokine expression
18. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
19. Transition metals bind to glycated proteins forming redox active glycochelates-implications for the pathogenesis of certain diabetic complications
20. Parkinson's disease: A major hypokinetic basal ganglia disorder
21. Early contribution of oxidative glycation of Alzheimer's disease
22. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
23. Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: Involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors
24. Distribution of advanced glycation end products in the cerebellar neurons of dogs
25. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors binding proteins
26. Understanding Parkinson's disease